PharmaShots | Incisive News in 3 Shots

Subscribe Now

Menstrual Bleeding

AbbVie and Neurocrine's Oriahnn Receive the US FDA's Approval as the First Oral Therapy for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women

AbbVie and Neurocrine's Oriahnn Receive the US FDA's Approval as the First Oral Therapy for the Management of Heavy Menstrual Blee...

May 29, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us